Recursion Pharmaceuticals, Inc. RXRX Purchases of intangible assets included in accrued expenses and other liabilities
Purchases of intangible assets included in accrued expenses and other liabilities at other companies
Other financials
Where this comes from
Reported directly by Recursion Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1.
The official record: Recursion Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Recursion Pharmaceuticals, Inc.'s purchases of intangible assets included in accrued expenses and other liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Recursion Pharmaceuticals, Inc.'s purchases of intangible assets included in accrued expenses and other liabilities?
- Recursion Pharmaceuticals, Inc. (RXRX) reported purchases of intangible assets included in accrued expenses and other liabilities of $1.92M in Q1 2026.
- What does purchases of intangible assets included in accrued expenses and other liabilities mean?
- Reflects the portion of intangible asset acquisitions that are settled through non-cash means or accrued liabilities rather than immediate cash payments. This metric is essential for understanding the total investment in intellectual property beyond what is captured in direct cash flow statements.